TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II Trial.

Antonio Llombart-Cussac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.